Inhibition of NF-jB activation increases susceptibility to tumor necrosis factor (TNF)a-induced cell death, concurrent with caspases and prolonged c-Jun N-terminal kinase (JNK) activation, and reactive oxygen species (ROS) accumulation. However, the detailed mechanisms are unclear. Here we show that cellular FLICE-inhibitory protein 
Introduction
NF-kB is a collective term of dimeric transcriptional factors that belong to the Rel family of proteins, and regulates expression of various inflammatory cytokines, chemokines, and adhesion molecules (Ghosh and Karin, 2002) . NF-kB is activated by various inflammatory cytokines and cellular stress including tumor necrosis factor (TNF)a, interleukin-1 (IL-1), UV, and g-irradiation. Moreover, NF-kB, especially the RelA-containing complex, inhibits cell death induced by TNFa, Fas ligand, TRAIL, and genotoxic stress. Currently, the antiapoptotic functions of NF-kB are supported to be mainly mediated by the upregulation of antiapoptotic genes such as cellular FLICE-inhibitory protein (c-Flip), the members of the Bcl-2 family, and X-chromosome-linked inhibitor of apoptosis (Xiap) (Karin and Lin, 2002) . However, the detailed molecular mechanisms are not completely understood.
The regulation of cell death and survival is also controlled in part by another signaling cascade activated by the mitogenactivated protein kinase (MAPK) following cellular stress or cytokine signaling (Davis, 2000; Kyriakis and Avruch, 2001) . In mammals, the MAPK cascades are composed of three distinct signaling modules, the c-Jun N-terminal kinase (JNK), the p38MAPK, and the extracellular signal-regulated kinase (ERK) cascades. Each MAPK is activated by sequential protein phosphorylation through a MAPK module. In the case of the JNK cascade, the MAP kinase kinase kinases (MAPKKKs) include apoptosis-signal-regulating kinase (ASK)1, MAP/ERK kinase kinases (MEKKs), MTK1 (also known as MEKK4), and TGFb-activated kinase (TAK)1. These MAPKKKs activate MAP kinase kinase (MKK)4 and/ or MKK7, which in turn activate JNKs (Davis, 2000; Kyriakis and Avruch, 2001 ). Cytokines and growth factors including TNFa and IL-1 induce rapid (within 10 min) yet transient MAPK activation, cellular stress, such as UV-or g-irradiation, induces prolonged MAPK activation. Several lines of evidence suggest that transient MAPK activation is associated with gene expression, proliferation, and differentiation, whereas prolonged MAPK activation promotes cell death in a celltype-and stimuli-dependent manner (Chen et al, 1996; Guo et al, 1998) .
In the past, the contributions of the NF-kB and JNK pathways have been discussed independently. However, two recent studies have revealed that inhibition of NF-kB activation induces prolonged JNK activation that promotes TNFainduced cell death (De Smaele et al, 2001; Tang et al, 2001) . Later studies have shown that TNFa-induced accumulation of reactive oxygen species (ROS) is enhanced in NF-kB activation-deficient cells including RelA À/À , IkB kinase b À/À , and TNF receptor-associated factor (traf)2 À/À traf5 À/À murine embryonic fibroblasts (MEFs) (Sakon et al, 2003; Pham et al, 2004; Ventura et al, 2004; Kamata et al, 2005) . Notably, this TNFa-induced ROS accumulation and prolonged JNK activation are completely suppressed by antioxidants, but not caspase inhibitors, indicating that TNFa-induced ROS accumulation is caspase-independent in NF-kB activation-deficient MEFs. Furthermore, expression of antioxidant enzyme genes including manganese-dependent superoxide dismutase (Mnsod) and ferritin heavy chain (fhc) is upregulated by TNFa in an NF-kB-dependent manner, and the ectopic expression of these genes inhibits TNFa-induced ROS accumulation in NF-kB-deficient MEFs (Pham et al, 2004; Kamata et al, 2005) . Although these studies have revealed that the caspase-independent pathway plays a crucial role in ROS accumulation, a recent study has shown that activated caspase-3 cleaves the p75 subunit of complex I of the mitochondrial electron transport chain, which would impair the function of complex I, resulting in ROS accumulation (Ricci et al, 2004) . In addition, Giorgio et al (2005) have shown that proapoptotic signals induce the release of p66 Shc from a putative inhibitory complex and the released p66
Shc then oxidizes reduced cytochrome c, thereby generating ROS. Therefore, the mechanisms whereby TNFa induces ROS accumulation are still controversial (Papa et al, 2004b; Luo et al, 2005; Nakano et al, 2006) . c-FLIP, also designated as CASH or Casper, was first identified as a molecule that interacts with FADD or is structurally related to procaspase-8 (Goltsev et al, 1997; Irmler et al, 1997; Shu et al, 1997) . c-Flip encodes two splicing variants, long form of c-FLIP (c-FLIP L ) and short form of c-FLIP (c-FLIP s ). While c-FLIP S only contains two N-terminal death effector domains (DEDs), c-FLIP L consists of the N-terminal DEDs and a C-terminal caspase-like domain that does not possess enzymatic activity. Many studies have shown that both c-FLIP L and c-FLIP S inhibit death receptorinduced apoptosis by binding to and inhibiting caspase-8 activation via DED-DED interaction (Thome and Tschopp, 2001 ). Consistently, c-Flip À/À cells showed an increased susceptibility to TNFa-and Fas ligand-induced cell death (Yeh et al, 2000) . Moreover, recent studies have shown that c-FLIP and viral FLIP are also involved in the Wnt signaling pathways (Naito et al, 2004; Nakagiri et al, 2005) .
In the present study, we have shown that c-FLIP L is rapidly degraded after TNFa stimulation, and the ectopic expression of c-FLIP L inhibits the TNFa-induced ROS accumulation and prolonged JNK activation in NF-kB activation-deficient MEFs. Conversely, TNFa induces prolonged JNK and ERK activation, and ROS accumulation in c-Flip with the appearance of a degradation fragment of 43 kDa ( Figure 1A) . Notably, MEFs appeared to express 55 kDa c-FLIP L , but not 26 kDa c-FLIPs. A similar degradation fragment was also observed in WT MEFs after TNFa stimulation, while the levels of c-FLIP L were not apparently reduced. When pretreated with a protein synthesis inhibitor, cycloheximide (CHX), c-FLIP L was progressively lost also in WT MEFs ( Figure 1B ). These results indicate that TNFa induces rapid degradation of c-FLIP in both WT and NF-kB activationdeficient MEFs, but the expression levels of c-FLIP L are maintained in WT MEFs by NF-kB-dependent de novo synthesis. It has been shown that the processing of c-FLIP L to the p43 fragment is mediated by caspase-8 (Shu et al, 1997; Kataoka and Tschopp, 2004) , and c-FLIP levels are also controlled in part by the ubiquitin/proteasome pathway (Kreuz et al, 2001; Micheau et al, 2001) . Consistently, the TNFa-induced degradation of c-FLIP L at early time points was partially inhibited by z-VAD-fmk or a proteasome inhibitor, MG132, in RelA À/À and traf2 Figure S1) . Therefore, the TNFa-induced rapid degradation of c-FLIP L may be at least partly mediated by caspases and the ubiquitin/proteasome pathway.
c-FLIP L inhibits TNFa-induced ROS accumulation and prolonged JNK activation
Consistent with our previous study (Sakon et al, 2003) , TNFa-induced ROS accumulation and prolonged JNK activation are suppressed by an antioxidant, butylated hydroxyanisole (BHA), but not a broad caspase inhibitor, z-VAD-fmk in RelA À/À and traf2 Figure   S2A ). This indicates that ROS accumulation and prolonged JNK activation are induced in a caspase-independent manner in these cells. Figure 1C ), suggesting that c-FLIP L might also suppress the caspase-independent pathway leading to ROS accumulation. TNFa-induced JNK activation at 10 min was not different between WT and RelA À/À MEFs, but this early phase JNK activation was severely impaired in traf2 Figure S2B) . Intriguingly, c-FLIP L specifically inhibited the sustained (at 120 min), but not early (at 10 min), phase of JNK activation in RelA À/À and traf2
MEFs ( Figure 1D ). Moreover, expression of c-FLIP L substantially increased cell viability after TNFa stimulation in RelA À/À and traf2 Figure 1E ). Taken that TNFa induces caspase-dependent and -independent cell death in NF-kB activation-deficient cells (Sakon et al, 2003) , these results indicate that ectopic expression of c-FLIP L is sufficient for suppression of TNFa-induced ROS accumulation, prolonged JNK activation, and cell death through suppression of the caspase-dependent and -independent pathways in NF-kB activation-deficient cells.
TNFa induces ROS accumulation and prolonged JNK activation in c-Flip À/À MEFs
To test directly whether c-FLIP L is essential for suppression of JNK activation and ROS accumulation, we first investigated the time course of caspase-3 activities after TNFa stimulation in c-Flip À/À MEFs. TNFa did not induce activation of caspase-3 in WT MEFs, unless the cells were stimulated with TNFa in the presence of CHX (Figure 2A ). In sharp contrast, TNFa stimulation induced a robust activation of caspase-3 at 1 h and then continued at 2 h, which was completely suppressed in the presence of z-VAD-fmk or z-VAD-fmk plus BHA, but not BHA in c-Flip À/À MEFs ( Figure 2A ). We next tested whether JNK activation is prolonged in c-Flip À/À MEFs.
While TNFa stimulation only induced transient JNK activation in WT MEFs, the sustained phase of JNK activation gradually appeared at 1 h after stimulation in c-Flip
MEFs, which was completely suppressed by z-VAD-fmk ( Figure 2B ). However, JNK activation continued at 2 h even in the presence of z-VAD-fmk, and this activation was substantially inhibited by the further addition of BHA. These results suggest that the caspase-dependent pathway plays a dominant role in JNK activation at 1 h. This is then followed by the caspase-independent ROS-inducing pathway leading to JNK activation at 2 h. Similarly, TNFa-induced ERK activation was prolonged in c-Flip À/À MEFs. Phosphorylation of JNK and ERK in TNFa plus BHA-treated cells at 2 h appeared to decrease compared to TNFa plus zVAD-fmk-treated cells. Taken that BHA alone inhibited neither caspase activation nor ROS accumulation at 2 h ( Figure 2A and C), these decreases might not be due to direct inhibitory effect of BHA on JNK and ERK activation, but rather due to massive cell death of TNFa plus BHA-treated c-Flip À/À MEFs (data not shown). We tested whether TNFa induces ROS accumulation in c-Flip À/À MEFs. ROS slightly accumulated at 1 h, and then progressively accumulated at 2 h after stimulation in c-Flip
MEFs ( Figure 2C ). In contrast to NF-kB activation-deficient cells (Supplementary Figure S2A) , TNFa-induced ROS accumulation was significantly suppressed by z-VAD-fmk at 2 h after simulation. However, a substantial amount of ROS still accumulated in c-Flip À/À MEFs at 2 and 4 h even in the presence of z-VAD-fmk ( Figure 2C ). We could not evaluate ROS accumulation in TNFa-or TNFa plus BHA-stimulated c-Flip À/À MEFs at 4 h due to cell death. Consistent with an inhibitory effect on TNFa-induced JNK activation, BHA plus z-VAD-fmk almost completely suppressed TNFa-induced ROS accumulation at 2 and 4 h after stimulation. Together, these results suggest that both caspase-dependent and -independent pathways may play crucial roles in TNFa-induced prolonged JNK activation and ROS accumulation in c-Flip
MEFs. The reason why BHA could not inhibit caspase-dependent ROS accumulation is currently unknown. Similarly, another antioxidant, N-acetyl cystein, could not inhibit Figure 2D ).
Collectively, c-FLIP is essential for suppression of TNFainduced ROS accumulation, prolonged JNK activation, and cell death. We also tested whether deficiency of c-FLIP could affect the duration of the JNK pathway induced by other stimuli. Consistent with a previous study (Chen et al, 1996) , anisomycin and UV induced prolonged JNK activation even in WT MEFs (Supplementary Figure S3A and MEFs were stimulated with TNFa (10 ng/ml) in the absence or presence of CHX (10 mg/ml), z-VAD-fmk (zVAD) (50 mM), BHA (100 mM), or z-VAD-fmk (50 mM) plus BHA (100 mM) for the indicated times. Caspase-3 activities were measured by using fluorogenic substrates. Results are presented as mean7s.e.'s of triplicate samples. Caspase activities were not detected in z-VAD-fmk-or z-VAD-fmk plus BHA-treated cells. (B) WT and c-Flip À/À MEFs were stimulated as in (A), and then the lysates were analyzed as in Figure 1D . zB indicates z-VAD-fmk (50 mM) plus BHA (100 mM) treatment. (C) WT and c-Flip À/À MEFs were unstimulated (thin line) or stimulated (bold line) with TNFa (10 ng/ml) as in (A) for the indicated times, accumulated ROS were analyzed as in Figure 1C . NE (not examined) indicates that ROS accumulation was not analyzed due to massive cell death. (D) c-Flip À/À MEFs were stimulated with the indicated amounts of TNFa in the absence or presence of z-VAD-fmk (zVAD) (50 mM), BHA (100 mM), or z-VAD-fmk (50 mM) plus BHA (100 mM) for 14 h. Cell viability was determined by WST assay as in Figure 1E . *Po0.05 compared to TNFa plus z-VAD-fmk-treated cells. several studies have shown that c-FLIP L activates NF-kB under particular conditions (Kataoka et al, 2000; Golks et al, 2006) . To test the possibility that accumulation of ROS is due to impaired upregulation of fhc and/or Mnsod genes in c-Flip À/À MEFs, we first investigated whether TNFa-induced IkBa degradation is impaired in c-Flip À/À MEFs. Consistent with a previous study (Yeh et al, 2000) , TNFa-induced degradation of IkBa was not impaired in c-Flip À/À MEFs ( Figure 3A) . Moreover, TNFa-induced upregulation of fhc and Mnsod mRNAs were not significantly different up to 120 min after TNFa stimulation in WT and c-Flip À/À MEFs ( Figure 3B ). We could not investigate the induction of mRNAs of these genes at later time points after 120 min, as almost all c-Flip À/À MEFs died.
To further explore the mechanism underlying c-FLIPdependent suppression of the ERK and JNK pathways, we examined whether TNFa-induced MEK1 phosphorylation is prolonged in c-Flip À/À MEFs. Phosphorylation of endogenous MEK1 was detected at 10 min upon TNFa stimulation in both WT and c-Flip À/À MEFs. Notably, phosphorylation of MEK1 reappeared at 60 min and persisted up to 120 min in c-Flip
MEFs ( Figure 3C ), whereas phosphorylation of MEK1 disappeared at 60 min in WT MEFs. The decrease in the size of phosphorylated MEK1 at 120 min in c-Flip À/À MEFs might be due to a degradation of MEK1. However, at least under our experimental conditions, we could not detect phosphorylation of endogenous MKK7 upon TNFastimulation possibly due to a poor sensitivity of the antibody to recognize phosphorylated MKK7 (data not shown). Collectively, these results indicate that TNFa induces prolonged ERK and JNK activation through activation of MEK1 and possibly MKK7 in c-Flip À/À MEFs, which are not suppressed by NF-kB-inducible genes other than c-Flip.
c-FLIP L inhibits JNK and ERK activation
Taken that TNFa-induced ROS accumulation is abolished in
) MEFs (Ventura et al, 2004) and the above results together, we surmised that c-FLIP L might directly inhibit the JNK pathway. Thus, we first tested whether c-FLIP L inhibits phosphorylation of MAPKs triggered by MAPKKKs including MEKK1, ASK1, and TAK1, which have been implicated in TNFa-induced MAPK activation (Nishitoh et al, 1998; Yuasa et al, 1998; Sato et al, 2005) . We transfected HEK293 cells with HA-tagged MAPKs along with a constitutively active form of MEKK1 (MEKK1DN) Figure 5F ). Together, c-FLIP L physically interacts with MKK7 and MEK1 in a TNFa-dependent manner. We next investigated the mechanism whereby c-FLIP L inhibits the MKK7-JNK and MEK1-ERK pathways. One possible scenario is that the binding of c-FLIP L to MKK7 or MEK1 might disrupt the interaction of MKK7 or MEK1 with MEKK1, thereby suppressing the MEKK1-induced MKK7 or MEK1 activation. A previous study has shown that once MEKK1 binds to and phosphorylates MKK4, MEKK1 rapidly dissociates with the phosphorylated MKK4 (Xia et al, 1998) . Consistently, we could not detect the interaction of the WT MKK7 with MEKK1 in co-immunoprecipitation experiments (data not shown). As we previously observed the stable interaction of a kinase-inactive mutant MKK7 (MKK7-KM) with MEKK1 in co-transfection experiments (Takekawa et al, 2005) , we tested whether c-FLIP L inhibits the interaction of MKK7-KM with MEKK1. Transfection of c-FLIP L inhibited the interaction of MKK7-KM with MEKK1DN in a dose-dependent manner ( Figure 5G) . Similarly, c-FLIP L inhibited the interaction of MEK1-KM with MEKK1DN ( Figure 5H ). Collectively, c-FLIP L inhibits the MKK7-JNK and MEK1-ERK pathways by disrupting the interactions of MKK7 or MEK1 with MEKK1. We also found that c-FLIP L inhibited the interaction of MKK7-KM with ASK1 or TAK1 (Supplementary Figure S4) . We could not detect the interaction of c-FLIP L with ASK1 or MEKK1 (data not shown).
The C-terminal caspase-like domain of c-FLIP L is responsible for the binding to MKK7
We determined the functional domain of c-FLIP L that binds to and suppresses the MKK7-JNK pathway. We constructed expression vectors for c-FLIPs and c-FLIPDN lacking the N-terminal DEDs. We investigated whether these mutants interact with MKK7. While both c-FLIP L and c-FLIPDN efficiently interacted with MKK7, c-FLIPs did not ( Figure 6B ). Consistently, expression of c-FLIPDN, but not c-FLIPs inhibited the MEKK1DN-induced MKK7 and JNK phosphorylation ( Figure 6C and D) , indicating that the binding of c-FLIP L to MKK7 is tightly correlated with the inhibitory effect of c-FLIP L on the MKK7-JNK pathway. To further delineate the binding region of c-FLIP L to MKK7, we constructed a series of deletion mutants of c-FLIP L and tested their ability to interact with MKK7 ( Figure 6A ). Notably c-FLIP L DC(À220) interacted with MKK7, but could not inhibit the MKK7-JNK pathway ( Figure  6E-G) . Taken that c-FLIP L DC(À153) bound to and inhibited MKK7 activation, the residues 203-260 are sufficient for the binding of c-FLIP L to MKK7, but additional residues 261-327 are required for inhibition of the MKK7-JNK pathway. Consistent with this notion, the residues 261-327 was required to inhibit the interaction of MEKK1 with MKK7, as c-FLIP L DC(À220) lost the ability to inhibit the binding of MEKK1 to MKK7 ( Figure 6H ). Figure S4) . Together, c-FLIP L has two distinct functions, one is inhibition of the caspase pathway via the N-terminal DED, and the other is suppression of the JNK pathway via the C-terminal caspase-like domain. Although our present study has revealed that c-FLIP Ldependent suppression of the JNK pathway is to disrupt the interaction of MKK7 with MAPKKKs, it is also likely that c-FLIP L might suppress the MKK7-induced JNK activation. Consistent with this possibility, we observed that c-FLIP L inhibited JNK activation induced by a constitutive active form MKK7, MKK7-3E, in which two serines and one threonine at the activation loop motif were mutated to glutamic acids (Holtmann et al, 1999) (Supplementary Figure S5) . Moreover, our preliminary study showed that the binding domain of MKK7 to c-FLIP L was mapped to the N-terminal region of the MKK7 (data not shown), which has been shown to be responsible for the interaction with JNK (Tanoue et al, . This suggests that c-FLIP L disrupts the binding of MKK7 to JNK. Further study will be required to address this possibility. Taken that the interaction of c-FLIP L with MKK7 is induced in a TNFa-dependent manner ( Figure 5E and F), c-FLIP L might selectively downregulate the prolonged phase, but not the early phase JNK activation ( Figure 1D ). Taken that the interactions of c-FLIP L with MKK7 or MEK1 were weakly detected at 5 min after stimulation ( Figure 5E and F), these early and weak interactions might not be sufficient for inhibiting MKK7 and MEK1 activation. Consistently, TNFa-induced JNK and ERK activation at 10 min were not different between WT and c-Flip À/À MEFs, whereas JNK and ERK activation were enhanced at 1 and 2 h after TNFa stimulation in c-Flip À/À MEFs compared to WT MEFs ( Figure 2B ). Previous studies have shown that impaired upregulation of antioxidant enzyme genes including fhc and Mnsod is responsible for TNFa-induced ROS accumulation in NF-kB activation-deficient cells (Pham et al, 2004; Kamata et al, 2005) . Then, accumulated ROS inactivate MKPs, resulting in prolonged JNK activation . However, this scenario does not appear to be the case of c-Flip À/À MEFs, as expression of fhc and Mnsod mRNAs were not significantly different between WT and c-Flip À/À MEFs up to 2 h after TNFa stimulation ( Figure 3B ). Taken that MKPs dephosphorylate and inactivate MAPKs, but not MAPKKs, these results suggest that, in addition to ROS-dependent inactivation of MKPs, another mechanism might operate to induce prolonged MEK1 and possibly MKK7 activation in c-Flip À/À MEFs.
Reconstitution of c-FLIP L , but not c-FLIPs, completely inhibits TNFa-induced ROS accumulation, JNK activation, and cell death in c-Flip
Consistent with this notion, c-FLIP L inhibited activation of MEK1 and MKK7 (Figure 4 and Supplementary Figure S4) . A previous study has shown that GADD45b, which is induced in an NF-kB-dependent manner, binds to MKK7 and inhibits MKK7's kinase activity as competitive inhibition Expression levels of the transfected proteins were analyzed as in Figure 4A . (H) HEK293 cells were transfected with the indicated expression vectors. After immunoprecipitation (IP) with anti-Myc antibody, co-immunoprecipitated MKK7-KM was detected by immunoblotting with anti-HA antibody (top panels). Expression levels of the transfected proteins were analyzed as in Figure 5A . (Papa et al, 2004a) . Taken that both c-FLIP L and GADD45b bind to MKK7, it is interesting to test whether c-FLIP L could affect the interaction of GADD45b with MKK7. However, under our experimental conditions, we could not detect a substantial interaction of GADD45b with MKK7 in HEK293 cells (data not shown). One possible explanation to explain this discrepancy is that the interaction of GADD45b with MKK7 might take place in a cell-type-specific manner. Consistently, GADD45b-dependent JNK inhibition is predominant in T cells, but not MEFs (Amanullah et al, 2003; Papa et al, 2004a) . Therefore, the relation between the interactions of MKK7 with GADD45b and c-FLIP L is currently unknown and will be investigated in the future study. Collectively, c-FLIP L and GADD45b might cooperatively or independently inhibit the JNK pathway in a context-and cell type-dependent manner ( Figure 8A ). Chang et al (2006) have recently reported that JNK phosphorylates and activates a ubiquitin ligase, ITCH, that subsequently interacts with the caspase-like domain of c-FLIP L and promotes degradation of c-FLIP L . In this respect, the fact that c-FLIP L , but not c-FLIPs, binds to and inhibits JNK activation is particularly interesting (Figure 6 ). Under normal conditions, expression levels of c-FLIP L are sufficient for inhibition of the caspase cascade and the JNK pathway. However, once the expression levels of c-FLIP L are downregulated due to various pathological conditions, JNK activation is gradually induced. This prolonged JNK activation further promotes degradation of c-FLIP L in an ITCH-dependent manner (Chang et al, 2006) . This vicious cycle along with downregulation of antioxidants and other antiapoptotic proteins ultimately induces caspase activation and/or ROS accumulation, resulting in cell death through apoptosis or necrosis ( Figure 8B ).
Given that c-FLIP L does not appear to have an antioxidant function, but directly binds to MKK7 and inhibits JNK activation (Figures 4 and 5 tive feedback loop, thereby suppressing ROS accumulation in NF-kB activation-deficient cells. To address the possibility, it is essential to generate c-Flip À/À Jnk À/À mice. However, we cannot formally exclude the possibility that c-FLIP L directly suppresses ROS accumulation in an undetermined mechanism. In addition to this mechanism, c-FLIP also suppresses caspase-dependent ROS accumulation ( Figure 2C ). The caspase-dependent ROS accumulation was observed in c-Flip
MEFs and c-FLIP-knockdown tumor cell lines, such as HeLa, A549, and HCT116 cells, but not NF-kB activation-deficient cells ( Figure 2C , Supplementary Figure S2A , and data not shown). One possible explanation is that under these conditions, in which c-FLIP is lost before stimulation, caspase activation is rapidly induced, resulting in caspase-dependent ROS accumulation along with caspase-independent ROS accumulation (Figure 2A and C) . In contrast, in NF-kB activation-deficient cells, expression levels of c-FLIP L decrease upon TNFa stimulation (Figure 1 ). Under these conditions, caspase activation is gradually and weakly induced (Supplementary Figure S2C) , and this gradually and weakly increased caspase activation is not sufficient for promoting ROS accumulation. Therefore, synergistic interplay between the JNK pathway and ROS accumulation may play a dominant role in ROS accumulation (Ventura et al, 2004) . Taken that BHA, but not z-VAD-fmk, almost completely inhibited TNFa-induced ROS accumulation in NF-kB activationdeficient cells (Sakon et al, 2003) (Supplementary Figure  S2A) , BHA may specifically inhibit caspase-independent ROS accumulation. Further study will be required to elucidate the interplay between caspase-dependent and -independent ROS accumulation. Upregulation of c-FLIP L has been shown to be correlated with resistance to Fas-induced apoptosis in vitro in certain tumor cell lines and also associated with autoimmune diseases (Thome and Tschopp, 2001) . One of the strategies to treat these pathological conditions is to block the c-FLIP Lmediated suppression of caspase activation, thereby promoting apoptosis of tumor cells and autoreactive T cells. In addition, blocking the suppressive function of c-FLIP L on JNK activation might be an alternative strategy to treat these diseases, resulting in prolonged JNK activation-induced cell death. In this respect, the interaction of c-FLIP L with MKK7 might be an attractive target to develop new drugs to treat various diseases such as cancers and autoimmune diseases.
Materials and methods
Plasmids pcDNA3-HA-MEK1, pcDNA3-HA-MEK1-KM, and pcDNA3-HA-MKK6 were described previously (Takekawa et al, 2005) . pCR-HA-MKK4, pCR-HA-MKK7, and pCR-HA-JNK2 were generated by cloning PCR-amplified products from pCR-MKK4, pCR-MKK7, and pET-SAPKa (JNK2) (provided by E Nishida) as templates into pCR-HA vector, respectively. pCR-HA-MKK7-KM (K165M) was generated by using an in vitro mutagenesis kit (Stratagene). pCR-HA-p38 and pCR-HA-ERK2 were generated by cloning RT-PCR products of p38 and ERK2 into pCR-HA vector, respectively. pcDNA3-Myc-TAK1, pcDNA3-Myc-TAB1, pcDNA3-Myc-ASK1, and pcDNA3-Myc-Tlp-2 were provided by K Matsumoto, H Ichijo, and S Ley. An expression vector for a constitutively active MEKK1 (pcDNA3-Myc-MEKK1DN) was constructed by deleting N-terminal regulatory region of MEKK1 (1-1119) by PCR from pSRHis-MEKK1 (provided by S Ohno). pCRFlag-c-FLIP L and pCR-Flag-c-FLIPs were generated by cloning PCRamplified products from pcDNA3-CASHa and pcDNA3-CASHb (provided by D Wallach) into pCR-Flag vector, respectively. pCRFlag-c-FLIPDN was constructed by PCR to delete the N-terminal DEDs. A series of deletion mutants of c-FLIP L was generated by PCR to delete the indicated amino acids from the C-terminus.
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